Interactions between effectors linked to serotonin receptors

被引:29
作者
Berg, KA
Maayani, S
Clarke, WP
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78284 USA
[2] Mt Sinai Med Ctr, Dept Anesthesiol, New York, NY 10029 USA
来源
ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS | 1998年 / 861卷
关键词
D O I
10.1111/j.1749-6632.1998.tb10181.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In general, there are two types of interactions between effector signaling pathways, "Homologous" interactions are those that occur within a receptor system to alter its own responsiveness, for example the loss of responsiveness (desensitization) that ran occur upon agonist occupancy of a receptor. "Heterologous" interactions are those that occur between different receptor systems where the responsiveness of one receptor system is regulated (positively or negatively) by activation of another receptor system (i.e., "cross-talk"), Many if not all receptors, couple to multiple cellular effector pathways and alterations in the responsiveness of a receptor system can be effector pathway-dependent which underscores the importance of studying each effector coupled to a receptor. Regulation of receptor system responsiveness, and consequently the efficacy of drugs, is a highly dynamic process. Perhaps by exploiting these interactions, new targets for pharmacotherapy mag be uncovered which will provide for increased efficacy and specificity of drug action.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 24 条
[1]  
BARKER EL, 1993, MOL PHARMACOL, V44, P725
[2]  
BERG KA, 1994, MOL PHARMACOL, V45, P826
[3]  
BERG KA, 1994, MOL PHARMACOL, V46, P477
[4]   Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Scaramellini, C ;
Leff, P ;
Clarke, WP .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :94-104
[5]  
Berg KA, 1996, MOL PHARMACOL, V50, P1017
[6]  
BLIER P, 1990, J CLIN PSYCHIAT, V51, P14
[7]   HIPPOCAMPAL LONG-TERM DEPRESSION - ARACHIDONIC-ACID AS A POTENTIAL RETROGRADE MESSENGER [J].
BOLSHAKOV, VY ;
SIEGELBAUM, SA .
NEUROPHARMACOLOGY, 1995, 34 (11) :1581-1587
[8]  
CONN PJ, 1985, J PHARMACOL EXP THER, V234, P195
[9]   A UNIQUE SEROTONIN RECEPTOR IN CHOROID-PLEXUS IS LINKED TO PHOSPHATIDYLINOSITOL TURNOVER [J].
CONN, PJ ;
SANDERSBUSH, E ;
HOFFMAN, BJ ;
HARTIG, PR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (11) :4086-4088
[10]   SEROTONIN STIMULATES PHOSPHOLIPASE-A2 AND THE RELEASE OF ARACHIDONIC-ACID IN HIPPOCAMPAL-NEURONS BY A TYPE-2 SEROTONIN RECEPTOR THAT IS INDEPENDENT OF INOSITOLPHOSPHOLIPID HYDROLYSIS [J].
FELDER, CC ;
KANTERMAN, RY ;
MA, AL ;
AXELROD, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2187-2191